Pharmacological characterization of the dermorphin analog [Dmt1]DALDA, a highly potent and selective μ-opioid peptide
- 4 May 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 419 (1), 15-23
- https://doi.org/10.1016/s0014-2999(01)00946-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- P-glycoprotein-mediated transport of morphine in brain capillary endothelial cellsBiochemical Pharmacology, 1999
- Cardiovascular effects of a μ-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: Sites and mechanisms of actionAmerican Journal of Obstetrics and Gynecology, 1999
- Role of blood‐brain barrier P‐glycoprotein in limiting brain accumulation and sedative side‐effects of asimadoline, a peripherally acting analgaesic drugBritish Journal of Pharmacology, 1999
- Enhanced Antinociception of the Model Opioid Peptide [D-Penicillamine2,5] Enkephalin by P-Glycoprotein ModulationPharmaceutical Research, 1999
- 3‐Methoxynaltrexone, a selective heroin/morphine‐6β‐glucuronide antagonistFEBS Letters, 1997
- Etonitazene-induced antinociception in μ1 opioid receptor deficient CXBK mice: Evidence for a role for μ2 receptors in supraspinal antinociceptionLife Sciences, 1994
- Systemic analgesic activity and .delta.-opioid selectivity in [2,6-dimethyl-Tyr1, D-Pen2, D-Pen5]enkephalinJournal of Medicinal Chemistry, 1992
- Naloxonazine actions in vivoEuropean Journal of Pharmacology, 1986
- Dissociation of morphine's analgesic and respiratory depressant actionsEuropean Journal of Pharmacology, 1983
- Opiate receptors in mice: Genetic differencesLife Sciences, 1975